However, there is substantial upregulation of IL-38 in the intestinal mucosa from IBD patients (11, 35) at both molecular and cellular levels, correlating well with the disease severity, although IL-38 is classified as anti-inflammatory cytokine. Here, IL1F10 is linked to inflammatory bowel disease.